Literature DB >> 27127770

The effect of time interval on esophagectomy after neoadjuvant treatment.

Lieven Depypere1.   

Abstract

"Esophagectomy timing after neoadjuvant therapy for distal esophageal adenocarcinoma" published in the Annals of Thoracic Surgery (doi: 10.1016/j.athoracsur.2015.09.044) states that 30- and 90-day mortality after esophagectomy for adenocarcinoma in patients with neoadjuvant chemoradiation, is significantly higher in patients with a postradiation interval of 9 weeks or more. The authors suggest that a "wait and see" approach after neoadjuvant therapy for esophageal adenocarcinoma may not be safe.

Entities:  

Keywords:  Esophageal cancer; adenocarcinoma; esophagectomy; neoadjuvant therapy

Year:  2016        PMID： 27127770      PMCID： PMC4828736          DOI： 10.21037/atm.2016.01.28

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


  8 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.

Authors:  G Lin; S-Y Han; Y-P Xu; W-M Mao
Journal:  Dis Esophagus       Date:  2015-11-06       Impact factor: 3.429

3.  Does the timing of esophagectomy after chemoradiation affect outcome?

Authors:  Jae Y Kim; Arlene M Correa; Ara A Vaporciyan; Jack A Roth; Reza J Mehran; Garrett L Walsh; David C Rice; Jaffer A Ajani; Dipen M Maru; Manoop S Bhutani; James Welsh; Edith M Marom; Stephen G Swisher; Wayne L Hofstetter
Journal:  Ann Thorac Surg       Date:  2011-10-01       Impact factor: 4.330

4.  Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?

Authors:  Chien-Hong Chiu; Yin-Kai Chao; Hsien-Kun Chang; Chen-Kan Tseng; Sheng-Chieh Chan; Yun-Hen Liu; Wei-Hsun Chen
Journal:  Ann Surg Oncol       Date:  2013-12       Impact factor: 5.344

5.  Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.

Authors:  Christophe Mariette; Laetitia Dahan; Françoise Mornex; Emilie Maillard; Pascal-Alexandre Thomas; Bernard Meunier; Valérie Boige; Denis Pezet; William B Robb; Valérie Le Brun-Ly; Jean-François Bosset; Jean-Yves Mabrut; Jean-Pierre Triboulet; Laurent Bedenne; Jean-François Seitz
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

6.  Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer?

Authors:  Williams Tessier; Caroline Gronnier; Mathieu Messager; Flora Hec; Xavier Mirabel; William B Robb; Guillaume Piessen; Christophe Mariette
Journal:  Ann Thorac Surg       Date:  2014-02-14       Impact factor: 4.330

Review 7.  Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis.

Authors:  Sheraz R Markar; Alan Karthikesalingam; Marta Penna; Donald E Low
Journal:  Ann Surg Oncol       Date:  2013-11-09       Impact factor: 5.344

8.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Authors:  Joel Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard Goldberg; Krystyna Kiel; Christopher Willett; David Sugarbaker; Robert Mayer
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544
  8 in total
  2 in total

1.  Adherence to quality measures improves survival in esophageal cancer in a retrospective cohort study of the national cancer database from 2004 to 2016.

Authors:  Akash Adhia; Joseph Feinglass; Cary Jo Schlick; David Odell
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  Prognostic Factors for Recurrence in Esophageal Cancer Patients Treated With Neoadjuvant Therapy and Surgery: A Single-institution Analysis.

Authors:  Misbah Khan; Namra Urooj; Aamir Ali Syed; Shahid Khattak; Ather Kazmi; Mohammad I Ashraf; Sadaf Batool
Journal:  Cureus       Date:  2020-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.